News | April 25, 2023
Tricog raises US$ 8.5 million in series B2 funding
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
The summit to demonstrate revolutionary techniques and advanced medical procedures for treating CTO
AI-driven company anumana partnered with Novartis to drive the development of its electrocardiogram (ECG) AI algorithms to detect subclinical heart disease.
The two generic drugs have been launched under the brand names Jankey & Sitenali.
Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery
First and only FDA-approved device of its kind demonstrates consistently high rates of target limb salvage and freedom from clinically-driven target lesion revascularization
Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
Subscribe To Our Newsletter & Stay Updated
